Evidence map›Paper›PMID 31619590›Full record

ArticleJCI insight2019

Muscarinic receptors promote pacemaker fate at the expense of secondary conduction system tissue in zebrafish.

Martina S Burczyk, Martin D Burkhalter, Teresa Casar Tena, Laurel A Grisanti, Michael Kauk, Sabrina Matysik, Cornelia Donow, Monika Kustermann, Melanie Rothe, Yinghong Cui and 9 more

Open access · goldAbstract read
In one paragraph

Article in JCI insight, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Zebrafish in Cardiovascular Disease Research: from Model to Application.International journal of biological sciences · 2026
    Review
  5. Review
  6. Article
  7. Article
  8. Macrophage-enriched novel functional long noncoding RNAs LRRC75A-AS1 and GAPLINC regulate polarization and innate immune responses.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2024
    Article
  9. Review
  10. Article
  11. Review
  12. Zebrafish Heart Failure Models.Frontiers in cell and developmental biology · 2021
    Review
  13. Fibroblast Growth Factor (FGF) 13.Differentiation; research in biological diversity
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 5 institutions in 4 countries.

Martina S BurczykInstitute of Biochemistry and Molecular Biology, Ulm University, Ulm, Germany.
Martin D BurkhalterInstitute of Biochemistry and Molecular Biology, Ulm University, Ulm, Germany.
Teresa Casar TenaInstitute of Biochemistry and Molecular Biology, Ulm University, Ulm, Germany.
Laurel A GrisantiCenter for Translational Medicine and Department of Pharmacology, Lewis Katz School of Medicine, Temple University, Philadelphia, Pennsylvania, USA.
Michael KaukInstitute for Molecular Cell Biology, University Hospital Jena, Friedrich-Schiller University of Jena, Jena, Germany.
Sabrina MatysikInstitute of Biochemistry and Molecular Biology, Ulm University, Ulm, Germany.
Cornelia DonowInstitute of Biochemistry and Molecular Biology, Ulm University, Ulm, Germany.
Monika KustermannInstitute of Biochemistry and Molecular Biology, Ulm University, Ulm, Germany.
Melanie RotheInstitute of Biochemistry and Molecular Biology, Ulm University, Ulm, Germany.
Yinghong CuiMolecular Signaling Section, Laboratory of Bioorganic Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland, USA.
Farah RaadInstitute of Pharmacology and Toxicology, University Medical Center Göttingen, Göttingen, Germany.
Svenja LaueMedical Department - Molecular Cardiology, Technical University Munich, Munich, Germany.
Allessandra MorettiMedical Department - Molecular Cardiology, Technical University Munich, Munich, Germany.
Wolfram-H ZimmermannInstitute of Pharmacology and Toxicology, University Medical Center Göttingen, Göttingen, Germany.
Jürgen WessMolecular Signaling Section, Laboratory of Bioorganic Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland, USA.
Michael KühlInstitute of Biochemistry and Molecular Biology, Ulm University, Ulm, Germany.
Carsten HoffmannInstitute for Molecular Cell Biology, University Hospital Jena, Friedrich-Schiller University of Jena, Jena, Germany.
Douglas G TilleyCenter for Translational Medicine and Department of Pharmacology, Lewis Katz School of Medicine, Temple University, Philadelphia, Pennsylvania, USA.
Melanie PhilippInstitute of Biochemistry and Molecular Biology, Ulm University, Ulm, Germany.
Universität Ulm · DENational Institutes of Health · USTechnical University of Munich · DETemple University · USUniversitätsmedizin Göttingen · DE

Funding

Progenitor Cell Biology Consortium Administrative Coordinating CenterU01HL099997 · NHLBI · UNIVERSITY OF MARYLAND BALTIMORE · PI TERRIN, MICHAEL L · 2009 to 2015
$29.9M
Molecular Mechanisms of Cardiac beta1AR-EGFR Association and SignalingR01HL105414 · NHLBI · THOMAS JEFFERSON UNIVERSITY · PI TILLEY, DOUGLAS · 2011 to 2019
$3.4M
NHLBI NIH HHS R01 HL105414NHLBI NIH HHS U01 HL099997
6 · The paper itself

Abstract

Deterioration or inborn malformations of the cardiac conduction system (CCS) interfere with proper impulse propagation in the heart and may lead to sudden cardiac death or heart failure. Patients afflicted with arrhythmia depend on antiarrhythmic medication or invasive therapy, such as pacemaker implantation. An ideal way to treat these patients would be CCS tissue restoration. This, however, requires precise knowledge regarding the molecular mechanisms underlying CCS development. Here, we aimed to identify regulators of CCS development. We performed a compound screen in zebrafish embryos and identified tolterodine, a muscarinic receptor antagonist, as a modifier of CCS development. Tolterodine provoked a lower heart rate, pericardiac edema, and arrhythmia. Blockade of muscarinic M3, but not M2, receptors induced transcriptional changes leading to amplification of sinoatrial cells and loss of atrioventricular identity. Transcriptome data from an engineered human heart muscle model provided additional evidence for the contribution of muscarinic M3 receptors during cardiac progenitor specification and differentiation. Taken together, we found that muscarinic M3 receptors control the CCS already before the heart becomes innervated. Our data indicate that muscarinic receptors maintain a delicate balance between the developing sinoatrial node and the atrioventricular canal, which is probably required to prevent the development of arrhythmia.

Indexed as

AnimalsArrhythmias, CardiacDisease Models, AnimalEmbryo, MammalianEmbryo, NonmammalianHeart Conduction SystemHEK293 CellsHumansMiceMice, KnockoutMuscarinic AntagonistsMyocytes, CardiacOrganogenesisReceptor, Muscarinic M3Tolterodine TartrateXenopus laevisMuscarinic AntagonistsReceptor, Muscarinic M3Tolterodine TartrateArrhythmiasCardiologyDevelopmentEmbryonic developmentG-protein coupled receptors

Identifiers

PMID31619590
PMCPMC6824298
OpenAlexW2980493900

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.